Cargando…
The Case for Angioplasty in Patients with Symptomatic Intracranial Atherosclerosis
Intracranial atherosclerotic disease (ICAD) is likely the most common cause of stroke worldwide and remains highly morbid even with highly monitored medical therapy. Recent results of the SAMMPRIS trial, which randomized patients to stenting plus aggressive medical management versus aggressive medic...
Autores principales: | McTaggart, Ryan A., Marks, Michael P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3990039/ https://www.ncbi.nlm.nih.gov/pubmed/24782816 http://dx.doi.org/10.3389/fneur.2014.00036 |
Ejemplares similares
-
Angioplasty and stenting for patients with symptomatic intracranial atherosclerosis: study protocol of a randomised controlled trial
por: Cui, Xiao-Ping, et al.
Publicado: (2016) -
Reviving Intracranial Angioplasty and Stenting “SAMMPRIS and beyond”
por: Farooq, Muhammad U., et al.
Publicado: (2014) -
Primary balloon angioplasty for symptomatic, high-grade intracranial stenosis
por: Tomycz, Luke, et al.
Publicado: (2013) -
Balloon Angioplasty vs. Stenting for Symptomatic Intracranial Arterial Stenosis
por: Sun, Yaxuan, et al.
Publicado: (2022) -
Percutaneous angioplasty and/or stenting versus aggressive medical therapy in patients with symptomatic intracranial atherosclerotic stenosis: a 1-year follow-up study
por: Li, Xiaohui, et al.
Publicado: (2023)